Moreover, the increase in HIF-1α induced by BRAF (V600E) mutation might significantly contribute to melanoma genesis in association with the PI3K/AKT/mTOR pathway, which is known to play a relevant role in early melanoma as well as resistance to BRAFi/MEKi therapy [25]. The gene discussed is HIF1A; the disease is melanoma.